Norplant and contraceptive pricing
Subtitle: conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1994
Place of publication: Washington
Subjects: Norgestrel -- Prices -- United States.; Contraceptives -- Prices -- United States.; Drugs -- Research -- United States.; Research and development contracts, Government -- United States.; Research and development partnership -- United States.